You are here
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
SBC: BOULDER NONLINEAR SYSTEMS, INC. Topic: NIMH
DESCRIPTION (provided by applicant): Mental disease, including schizophrenia, depression and autism spectrum disorders, are still poorly understood, although it is clear that they mostly represent cortical disorders. The cortex is the primary site of higher mental functions, and despite extensive research, there is still no unified theory of how the cortex works. This is partl due to the fact that ...STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
SBC: GLSynthesis Inc. Topic: 300
DESCRIPTION provided by applicant This phase project has as its overall objectives to design engineer optimize and implement a novel genetically encoded fluorescent drug sensor FDS based on F rster Resonance Energy Transfer FRET by exploiting conformational rearrangements induced by drug interactions with human serum albumin SA SA is uniquely suited for a general drug sensor beca ...STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
A Novel, Field-Deployable, Biomimetic Narcotics Detector for the Identification of Fentanyl and Other Synthetic OpioidsSBC: SEACOAST SCIENCE, INC. Topic: NIDA
AbstractThe alarming scope of the rapidly growing opioid epidemic has commanded the nation’s attention. The White House’s Council of Economic Advisers estimates that in 2015, the economic cost of the opioid crisis was over $504.0 billion (2.8% of GDP); and it is only expected to continue rising. Today, 1 in 5 fatalities amongst young adults is opioid related; with half a million fatal overdose ...STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
A novel, hand-held, exhaled breath condensate sampler for the clinical research market; applications for asthma, pulmonary injury and inflammation.SBC: SENSIT VENTURES, INC. Topic: NIEHS
ABSTRACTExhaled breath is one of the most non-invasive human effluents that can be captured and analyzed, and yet it has minimal presence as a common clinical endpoint measurement in any branch of modern medicine. There has been a persistent technology gap for both breath sampling and breath analysis, despite the many vulnerable patient populations and age groups that could be aided by its use. Ex ...STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
SBC: Immunotox, Inc. Topic: N/A
The goal of this proposal is to develop a new treatment for strabismus, a visual disorder affecting 3-4% of the population, using a novel technology that we have recently formulated. This involves specific targeting and elimination of cholinergic motor neurons that innervate the extra-ocular muscles by injection of an antivesicular acetylcholine transporter-saporin (anti-VAChT-saporin). This appro ...STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
SBC: MEDCHEM PARTNERS LLC Topic: NIA
DESCRIPTION (provided by applicant): Even though the association of -amyloid peptide (A ) deposition and Alzheimer's Disease (AD) underpins the major hypothesis for disease progression and possibly causation and several drugs addressing the formation or removal of -amyloid plaques have entered clinical trials, no effective therapy exists to date for AD. This reality calls for new targets th ...STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
SBC: ADA TECHNOLOGIES, INC. Topic: N/A
DESCRIPTION (provided by applicant): Cancer treatment today is in need of tumor-specific and effective therapies that do not harm the patient and thereby compromise treatment efficacy and prolong recovery time. A multi-modal therapeutic and imaging agent t hat does not damage healthy living tissue would have tremendous benefit to researchers and victims of this deadly disease. Nanomaterials have t ...STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
SBC: Edenspace Systems Corporation Topic: N/A
DESCRIPTION (provided by applicant): Low levels of nutrients such as calcium contribute to osteoporosis and other significant health problems for millions of people worldwide. For many consumers, current methods of increasing dietary nutrients are inconvenient, costly, or unpalatable. This STTR Phase I project proposes to develop a novel method of increasing levels of one or more nutrients in veg ...STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
SBC: L2 DIAGNOSTICS LLC Topic: N/A
DESCRIPTION (provided by applicant): Thromboembolic disease is a major cause of morbidity and mortality in the developed world. Because platelets play a critical role in the activation and propagation of thrombosis, they represent important targets for new anti-thrombotic drugs. A potent inhibitor of human platelet function has been isolated from the bloodfeeding hookworm, Ancylostoma caninum. ...STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
SBC: MYCOLOGICS, INC. Topic: N/A
DESCRIPTION (provided by applicant): Cryptococcus neoformans is an encapsulated pathogenic yeast that causes pulmonary infections and meningoencephalitis in humans and other animals. During the last 20 years, there has been a dramatic increase in the incidence of cryptococcosis throughout the world that mirrors the increase in not only HIV infections, but also in the growing number of immuno comp ...STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health